Isoflavonoids and Epigenetic Modulation: Therapeutic Insights for Cancer Treatment

Area of Science:

• Natural Products Chemistry
• Epigenetics
• Oncology

Background:

• Isoflavonoids are a major flavonoid subgroup influencing cellular homeostasis via epigenetic reprogramming.
• Their potential as therapeutic agents in cancer, particularly hematological malignancies, is significant.
• Pterocarpans, a specific isoflavonoid subclass, possess notable biological activities.

Purpose of the Study:

• To review the biological mechanisms and therapeutic potential of isoflavonoids, focusing on epigenetic modulation in cancer.
• To highlight the chemical properties and translational applications of pterocarpans, specifically (+)-2,3,9-trimethoxypterocarpan.

Main Methods:

• In silico analysis using SwissADME to predict pharmacokinetic properties.
• Evaluation of molecular properties related to gastrointestinal absorption and blood-brain barrier penetration.
• Review of existing literature on pterocarpan biological activities and epigenetic effects.

Main Results:

• (+)-2,3,9-trimethoxypterocarpan demonstrates favorable in silico gastrointestinal absorption and blood-brain barrier permeability, adhering to Lipinski's rule.
• The molecule is suggested to be a P-glycoprotein substrate, indicating potential active efflux.
• Isoflavonoids act as epigenetic modulators, offering novel therapeutic avenues.

Conclusions:

• Isoflavonoids, particularly pterocarpans like (+)-2,3,9-trimethoxypterocarpan, represent a promising class of natural products for cancer therapy.
• Their epigenetic regulatory functions and favorable pharmacokinetic profiles support their development for oncology, including leukemia.
• Further translational research is warranted to explore their full therapeutic potential in cancer treatment.